Abengoa Bioenergy Invests in Dyadic

Dyadic International, Inc. (AMEX:DIL), has signed a three-year research and development (R&D) agreement and a stock purchase agreement with Abengoa Bioenergy R&D, Inc. (ABRD). Under the terms of the agreement, Abengoa Bioenergy will invest $10 million in Dyadic, for which it will receive  2,136,752 shares of Dyadic Common Stock.

Dyadic will use the proceeds from this private sale to fund R&D obligations called for in the agreement, which has as its objective the development of a cost-effective enzyme production system for commercial application in Abengoa Bioenergy’s bioethanol (cellulosic ethanol) production process. The R&D agreement calls upon Dyadic to use its proprietary technologies to develop one or more enzyme mixture manufacturing systems customized to ABRD’s proprietary biomass substrates.

Dyadic International, Inc. is engaged in the development, manufacture and sale of biological products using a number of proprietary fungal strains to produce enzymes and other biomaterials, principally focused on a system for protein production based on the patented Chrysosporium lucknowense fungus, known as C1. Dyadic is applying its technologies to produce enzymes for use in converting various agricultural products (e.g. corn) and waste products (e.g. switch grass, wheat straw, sugar cane bagasse, etc.) into fermentable sugars, which can then be used in the production of traditional and cellulosic ethanol as well as other products currently derived from petroleum.

it has identified and tested highly effective enzyme mixtures for the efficient conversion of renewable cellulosic biomass to ethanol.  The C1 genome has been sequenced, which will reduce the time required to bring a specific gene to market from years to months.

Abengoa Bioenergy, headquartered in St. Louis, Missouri, is a company dedicated to the development of biofuels for transport, including bioethanol and biodiesel, to support sustainable development.

Abengoa Bioenergy is considered to be the second largest ethanol producer in the world and a leader in the fields of both corn-derived and cellulose-derived ethanol production. Abengoa currently is building a 5 million liter per year cellulosic ethanol plant in the Salamanca region of Las Vilas in Spain, which it claims will be the worlds first commercial cellulosic ethanol plant.  Startup of the plant is scheduled for this year. Production of bioethanol from agricultural residues, specifically, corn stover and wheat straw, requires extensive processing to release the polymeric sugars in cellulose and hemicellulose that account for 30% to 50% and 20% to 35% of plant material, respectively. ABRD is developing a novel biomass-to-ethanol process, with emphasis on thermochemical fractionation and enzymatic hydrolysis to release these sugars for ethanol fermentation.

In November 2005 it finalized financing for 88 milion gallons per year corn ethanol manufacturing plant in Ravenna, Nebraska scheduled for completion in early 2007. Upon completion of the Ravenna facility, Abengoa Bioenergy will be able to produce 203 million gallons of ethanol in the U.S. each year, in addition to its current annual capacity of 85 million gallons in Spain, and with an additional 53 million gallon facility expected to be completed in Spain within the next few months. In May 2006 it started construction of first bioethanol facility in Europe that will utilize corn as the raw material. The Lacq facility will be capable of producing 200,000 tons of bioethanol utilizing corn and wine alcohol as raw material.

The U.S. Department of Energy and Abengoa Bioenergy R&D signed a 4-year, $35.5 million (U.S.) contract in 2003 to develop the technology for Advanced Biorefining of Distillers Grain and Corn Stover Blends.

Under this contract Abengoa Bioenergy R&D, in collaboration with Novozymes North America, Inc., the National Renewable Energy Laboratory (NREL), and Stake Technology, is developing novel biomass-derived process technology that utilizes advanced bio-refined Distiller's Grain and Corn Stover blends to achieve significantly higher bioethanol yields while maintaining the protein feed value.

Comments

[Shelly]

This is quite interesting. If you do the research, you'll see that not only does Abengoa have a partnership with Dyadic, but it also has a partnership with Novozymes. According to www.InvestInCellulosicEthanol.com, Novozymes has a partnership with Broin. It seems the entire cellulosic ethanol industry is a bit inbred. I sense some mergers coming. Typically, mergers mean good news for investors. As far as investments go, I think Abengoa and Dyadic are a pretty good bet. Few companies, if any, have such a clear leadership position in cellulosic ethanol technology.

[Dave]

Shelly,
I took your advice and went to http://www.investincellulosicethanol.com . That site rocks! Thanks for the tip!

[تقنية]

thanks for the good advice

[ティファニー 激安]

tiffany & coスウォッチ グループ ジャパンはこのほど、東京?銀座のニコラス?G?ハイエック センター内に「ティファニー ウォッチ ショールーム」をオープンした。男性向けの「アトラス ジェント スクエア クロノグラフ」、女性向けの「ティファニー ジェメア」をはじめ、希少性の高いアイテムも展示、販売される。Tiffany Rings
国内初のティファニー ウォッチ専門店となる同ショールームには、新作ウォッチがいち早く店頭に並ぶだけでなく、さまざまなフェアやイベントも開催される予定となっている。時計の専門知識を持つスタッフにより、利用客の要望にもきめ細かく対応するという。ティファニー 激安
同ショールームでも販売される「アトラス ジェント スクエア クロノグラフ」は、最高のムーブメントとして広く認められるフレデリック?ピゲ製自動巻キャリバー1285を搭載。さらに頑丈な40mmのステンレス スティール ケースとスポーティなデザインにより、毅然とした男の魅力を演出している。Tiffany ネックレス
「ティファニー ジェメア」は、18カラットのホワイトゴールドで作られた樽型のケースが特徴で、たくさんのダイヤモンドを散りばめた宝飾時計に仕上がっている。ダイヤモンド1列のモデルとダイヤモンド2列のモデルのほかに、時計の表面に610個のダイヤモンド(3.12カラット)を敷き詰めたフルパヴェのモデルも用意。Tiffany locksこれらの3モデルを、直径22mm / 18mmの2パターンで展開する。ティファニー
その他、ショールームのオープンを記念し、日本初登場となる「ステートメント ウォッチ」「5thアヴェニュー ウォッチ」なども特別展示されるティファニー。
アメリカを代表する世界のプレミア?ジュエラー、ティファニーは1837年の創設以来、時を越えて多くの人々を魅了してきた。ティファニーのジュエリー、シルバー、ウォッチ、そのデザインの数々は何世代にもわたって世界中で愛され続けている。ティファニー 通販

[生薬]

生薬

[アバクロ]

アバクロ

[RMT]

RMT

[女性用媚薬]

女性用媚薬

[天天素]

天天素

[buy prozac online]

Your points are very true and heart touching. I must try to keep these points in my mind. I am sure these points ‘ll definitely help me in future. Thanks for the tutorial.

[iPhone 4 ケース]

Your points are very true and heart touching. I must try to keep these points in my mind. I am sure these points ‘ll definitely help me in future. Thanks for the tutorial.

[Real Estate in Vietnam]

Dyadic's main focus for the development of a potent enzyme is based on patented strains of the fungal microorganism Chrysosporium lucknowense

[アバクロ]

s for the development of a potent enzyme is based on patented strains of the fungal microorganism Chrysosporium lucknowense